<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
-----------------------
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): DECEMBER 1, 1998
OMEGA PROTEIN CORPORATION
(Exact name of registrant as specified in its charter)
NEVADA 001-14003 76-0562134
(State or other jurisdiction (Commission File No.) (I.R.S. Employer
of incorporation) Identification No.)
1717 ST. JAMES PLACE
SUITE 550
HOUSTON, TEXAS 77056
(Address of principal executive offices)
(713) 623-0060
(Registrant's telephone number, including area code)
NOT APPLICABLE
(Former name or former address, if changed since last report)
<PAGE>
ITEM 8. CHANGE IN FISCAL YEAR
On December 1, 1998, the Company's Board of Directors approved a
change in the Company's fiscal year end from September 30 to December 31, to be
effective beginning January 1, 1999. The report on Form 10-Q covering the three
months ended December 31, 1998 (the transition period) will be filed in
accordance with the Securities and Exchange Commission filing requirements.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
OMEGA PROTEIN CORPORATION
By: /s/ Eric T. Furey
-------------------------------------
Eric T. Furey
Vice President, General Counsel and
Corporate Secretary
Date: December 15, 1998
3
